A Device Improves Signs and Symptoms of TMD

Background . Temporomandibular joint dysfunction (TMD) therapy remains an open challenge for modern dentistry. Herein, we propose a new neuromuscular lingual device able to reduce signs and symptoms of TMD in female patients with chronic orofacial pain. Methods . 50 females with myofascial TMD according to RDC/TMD were randomly assigned to study ( n = 25) and control groups ( n = 25). At T0, both groups received sEMG/KNG and pain evaluation by the VAS scale. The study group received the ELIBA device (lingual elevator by Balercia) constructed under ULF-TENS (ultra-low-frequency transcoutaneous electrical nervous stimulation). Subjects were instructed to use ELIBA at least for 16 h/day. After 6 months (T1), both groups underwent to sEMG/KNG and VAS revaluation. Results . T1 study group compared to controls showed a significant reduction in total ( p < 0.0001 ) and mean ( p < 0.0001 ) sEMG values, as well as a significant increase in both maximum vertical mouth opening ( p = 0.003 ) and maximum velocity in mouth opening ( p = 0.003 ) and closing ( p < 0.0001 ). Interestingly, a significant reduction in pain measured by VAS ( p < 0.0001 ) was reported. Conclusions . After 6 months, the ELIBA device is able to significantly reduce TMD-associated myogenous pain and to promote the enhancement of sEMG/KNG values. Practical Implications . ELIBA can be considered as a new device, potentially useful for head-neck pain relief in patients suffering from chronic TMD. In addition, its use promotes a muscles relaxation inducing freeway space increase. This characteristic makes it particularly useful for rehabilitation of patients with not enough space for construction of conventional orthotics or neuromuscular bites.